Cargando…
Comparison of the outcomes of sublobar resection and stereotactic body radiotherapy for stage T1-2N0M0 non-small cell lung cancer with tumor size ≤ 5 cm: a propensity score matching analysis
BACKGROUND: Surgery and stereotactic body radiotherapy (SBRT) are both suitable treatment options for early stage Non-small cell lung cancer (NSCLC), which accounts for the majority of lung cancer. This study compared the outcomes of sublobar resection (SLR) and SBRT in patients with stage T1-2N0M0...
Autores principales: | Dong, Baiqiang, Zhu, Xuan, Jin, Jianan, Chen, Yuanyuan, Ying, Hangjie, Chen, Yamei, Lu, Fangxiao, Shen, Wei, Wang, Jin, Chen, Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656409/ https://www.ncbi.nlm.nih.gov/pubmed/33209426 http://dx.doi.org/10.21037/jtd-20-2367 |
Ejemplares similares
-
Comparison of the outcomes of stereotactic body radiotherapy versus surgical treatment for elderly (≥70) patients with early-stage non-small cell lung cancer after propensity score matching
por: Dong, Baiqiang, et al.
Publicado: (2019) -
Video-Assisted Thoracoscopic Lobectomy Versus Stereotactic Body Radiotherapy Treatment for Early-Stage Non-Small Cell Lung Cancer: A Propensity Score-Matching Analysis
por: Dong, Baiqiang, et al.
Publicado: (2020) -
A propensity-matched analysis of stereotactic body radiotherapy and sublobar resection for stage I non-small cell lung cancer in patients at high risk for lobectomy: the results in a Chinese population
por: Yuan, Xiao-Shuai, et al.
Publicado: (2021) -
Propensity score-based analysis of stereotactic body radiotherapy, lobectomy and sublobar resection for stage I non-small cell lung cancer
por: Kishi, Noriko, et al.
Publicado: (2022) -
Sublobar resection versus lobectomy for patients with stage T1-2N0M0 pulmonary typical carcinoid tumours: a population-based propensity score matching analysis
por: Yang, Hao, et al.
Publicado: (2022)